AAAAAA
Results: 1-25/31
Authors:
MROSS K
HAUNS B
HARING B
BAUKNECHT T
MEERPOHL HG
UNGER C
MAIERLENZ H
Citation: K. Mross et al., CLINICAL-PHASE-I STUDY WITH ONE-HOUR PACLITAXEL INFUSION, Annals of oncology, 9(5), 1998, pp. 569-572
Authors:
MROSS K
RUTHER A
GIERLICH T
UNGER C
Citation: K. Mross et al., TUMOR-GROWTH CONTROL BY ORAL TROFOSFAMIDE IN PATIENTS WITH METASTATICBREAST-CANCER, Onkologie, 21(1), 1998, pp. 52-56
Authors:
KIRSTE T
HAUNS B
EICHELMANN A
BRINKMANN R
BELLER J
MROSS K
UNGER C
Citation: T. Kirste et al., COMPLETE REMISSION IN PATIENTS WITH PANCREATIC-CANCER - A RARE BUT SOMETIMES ACHIEVABLE EVENT, Onkologie, 21(1), 1998, pp. 64-66
Authors:
RUTHER A
WILLENBACHER W
MUMM A
MROSS K
UNGER C
BARTSCH HH
Citation: A. Ruther et al., PROS AND CONS REGARDING THE USE OF A CLINICAL INFORMATION-SYSTEM (CIS) IN ONCOLOGICAL ROUTINE, Bone marrow transplantation, 21, 1998, pp. 380-380
Authors:
LEHNERT M
MROSS K
SCHUELLER J
THUERLIMANN B
KROEGER N
KUPPER H
Citation: M. Lehnert et al., PHASE-II TRIAL OF DEXVERAPAMIL AND EPIRUBICIN IN PATIENTS WITH NONRESPONSIVE METASTATIC BREAST-CANCER, British Journal of Cancer, 77(7), 1998, pp. 1155-1163
Authors:
BROUWER E
VERWEIJ J
HAUNS B
LOOS WJ
NOOTER E
MROSS K
STOTER G
SPARREBOOM A
Citation: E. Brouwer et al., LINEARIZED COLORIMETRIC ASSAY FOR CREMOPHOR EL - APPLICATION TO PHARMACOKINETICS AFTER 1-HOUR PACLITAXEL INFUSIONS, Analytical biochemistry (Print), 261(2), 1998, pp. 198-202
Authors:
FIEBIG HH
BELZER J
KLOPFER P
CIAMANGO O
ARENDS J
MROSS K
UNGER C
Citation: Hh. Fiebig et al., SCALP HYPOTHERMIA FOR 2 HOURS PREVENTS ALOPECIA AFTER ADRIAMYCIN BASED CHEMOTHERAPY, European journal of cancer, 33, 1997, pp. 231-231
Authors:
MROSS K
FIEBIG HH
BERDEL W
BANKMANN Y
VONBROEN IM
WALTER N
UNGER C
Citation: K. Mross et al., CLINICAL AND PHARMACOKINETIC PHASE-I STUDY WITH CEMATODIN(R) GIVEN ASCONTINUOUS 24-HOUR INTRAVENOUS-INFUSION, European journal of cancer, 33, 1997, pp. 1122-1122
Authors:
MROSS K
HARING B
HAUNS B
MAIERLENZ H
BAUKNECHT T
MEERPOHL HG
DIERGARTEN K
UNGER C
Citation: K. Mross et al., CLINICAL AND PHARMACOKINETIC PHASE-I STUDY WITH TAXOL(R) GIVEN AS SHORT 1-HOUR INTRAVENOUS-INFUSION, European journal of cancer, 33, 1997, pp. 1135-1135
Authors:
STAUDER H
HARING RB
HAUNS B
KUHLMANN J
MAIERLENZ H
MENG G
MROSS K
UNGER C
Citation: H. Stauder et al., PHASE-II STUDY WITH 5-FLUOROURACIL AND GINKGO-BILOBA EXTRACT IN PATIENTS WITH PANCREAS CA, European journal of cancer, 33, 1997, pp. 1264-1264
Authors:
DUHRSEN U
HEINRICHS V
BEECKEN WD
HERBST K
MROSS K
HOSSFELD DK
Citation: U. Duhrsen et al., LOCAL AND SYSTEMIC SEQUELAE OF MEDIASTINAL DAUNORUBICIN EXTRAVASATIONIN A PATIENT WITH ACUTE MYELOMONOCYTIC LEUKEMIA, Annals of oncology, 8(11), 1997, pp. 1167-1168
Authors:
MAIERLENZ H
HAUNS B
HAERING B
KOETTING J
MROSS K
UNGER C
BAUKNECHT T
DUBOIS A
MEERPOHL HG
HOLLAENDER N
DIERGARTEN K
Citation: H. Maierlenz et al., PHASE-I STUDY OF PACLITAXEL ADMINISTERED AS A 1-HOUR IN FUSION - TOXICITY AND PHARMACOKINETICS, Seminars in oncology, 24(6), 1997, pp. 16-19
Authors:
MROSS K
REIFKE J
BEWERMEIER P
KRUGER W
HOSSFELD DK
ZANDER A
Citation: K. Mross et al., THE PHARMACOKINETICS AND TOXICITY OF 2 APPLICATION SCHEDULES WITH HIGH-DOSE VP-16 IN PATIENTS RECEIVING AN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Annals of oncology, 7(1), 1996, pp. 83-88
Authors:
MROSS K
HERBST K
BERDEL WE
KORFEL A
VONBROEN IM
BANKMANN Y
HOSSFELD DK
Citation: K. Mross et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF LU103793 (CEMADOTIN HYDROCHLORIDE) AS AN INTRAVENOUS BOLUS INJECTION IN PATIENTS WITH METASTATIC SOLID TUMORS - A STUDY OF THE AIO PHASE-I AND APOH GROUP OF THE GERMAN-CANCER-SOCIETY, Onkologie, 19(6), 1996, pp. 490-495
Authors:
MROSS K
HUTTMANN A
HERBST K
HANAUSKE AR
SCHILLING T
MANEGOLD C
BURK K
HOSSFELD DK
Citation: K. Mross et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NEW PODOPHYLLOTOXIN DERIVATIVE NK-611 - A STUDY BY THE AIO-GROUPS PHASE-I AND APOH, Cancer chemotherapy and pharmacology, 38(3), 1996, pp. 217-224
Authors:
KRUGER W
KRZIZANOWSKI C
HOLWEG M
STOCKSCHLADER M
KROGER N
JUNG R
MROSS K
JONAT W
ZANDER AR
Citation: W. Kruger et al., REVERSE TRANSCRIPTASE POLYMERASE CHAIN-REACTION DETECTION OF CYTOKERATIN-19 MESSENGER-RNA IN BONE-MARROW AND BLOOD OF BREAST-CANCER PATIENTS/, Journal of cancer research and clinical oncology, 122(11), 1996, pp. 679-686
Authors:
KRUGER W
SOBOTTKA I
STOCKSCHLADER M
MROSS K
HOFFKNECHT M
RUSSMANN B
HORSTMANN M
BETKER R
ZANDER A
Citation: W. Kruger et al., FATAL OUTCOME OF DISSEMINATED CANDIDOSIS AFTER ALLOGENEIC BONE-MARROWTRANSPLANTATION UNDER TREATMENT WITH LIPOSOMAL AND CONVENTIONAL AMPHOTERICIN-B - A REPORT OF 4 CASES WITH DETERMINATION OF THE MIC VALUES, Scandinavian journal of infectious diseases, 28(3), 1996, pp. 313-316
Authors:
KROGER N
LEHNERT M
MROSS K
GIESEKING F
THURLIMANN B
SCHULLER J
KUPPER H
HOSSFELD DK
Citation: N. Kroger et al., DEXVERAPAMIL TO OVERCOME ANTHRACYCLINE-RESISTANCE IN ADVANCED BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 361-361
Authors:
MROSS K
Citation: K. Mross, MULTIDRUG-RESISTANCE MODULATION IN METASTATIC BREAST-CANCER PATIENTS, Journal of clinical oncology, 13(1), 1995, pp. 303-304
Authors:
KROGER N
ZSCHABER R
KRUGER W
ZELLER W
MROSS K
ZANDER A
HOSSFELD DK
Citation: N. Kroger et al., DOSE INTENSITY OF CHEMOTHERAPY IN BREAST-CANCER - RESULTS OF CLINICAL-STUDIES, Onkologie, 18(5), 1995, pp. 419-428
Authors:
HERRMANN R
MROSS K
KLEEBERG U
BECHER R
EDLER L
QUEISSER W
LIATI P
KERPELFRONIUS S
Citation: R. Herrmann et al., 4'-IODO-4'-DEOXYDOXORUBICIN (IDX) IN COLORECTAL-CANCER - A MULTICENTER PHASE-II STUDY, Onkologie, 18(1), 1995, pp. 28-30
Authors:
KROGER N
MROSS K
GIESEKING F
LEHNERT M
THURLIMANN B
SCHULLER J
KUPPER H
HOSSFELD DK
Citation: N. Kroger et al., DEXVERAPAMIL AS RESISTANCE MODULATOR IN A NTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER - INTERIM RESULT OF A PHASE-II STUDY, Onkologie, 18(1), 1995, pp. 95-95
Authors:
STOCKSCHLADER M
KRUGER W
DIECK A
MROSS K
BERGER C
ERTTMANN R
CLAUSEN J
HOFFKNECHT M
ZANDER A
Citation: M. Stockschlader et al., CRYOPRESERVATION OF RELATED AND UNRELATED STEM-CELLS FOR ALLOGENEIC TRANSPLANTATION, Experimental hematology, 23(8), 1995, pp. 866-866
Authors:
STOCKSCHLADER M
HEGEWISCHBECKER S
KRUGER W
DIECK AT
MROSS K
HOFFKNECHT M
BERGER C
KOHLSCHUTTER B
MARTIN H
PETERS S
KABISCH H
KUSE R
WEH H
ZANDER A
Citation: M. Stockschlader et al., BONE-MARROW TRANSPLANTATION FOR PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA, Bone marrow transplantation, 16(5), 1995, pp. 663-667
Authors:
MROSS K
Citation: K. Mross, BONE-MARROW TRANSPLANTATION VERSUS CHEMOTHERAPY IN NON-HODGKINS-LYMPHOMA, The New England journal of medicine, 333(11), 1995, pp. 728-728